title: Clozapine replacement by quetiapine for the treatment of drug-induced psychosis in Parkinson's disease.
authors.affiliation: Division of Neurology, Memorial Hospital of Rhode Island, Pawtucket 02860, USA.
authors.forename: H H
authors.initials: HH
authors.lastname: Fernandez
authors.forename: M C
authors.initials: MC
authors.lastname: Lannon
authors.forename: J H
authors.initials: JH
authors.lastname: Friedman
authors.forename: B P
authors.initials: BP
authors.lastname: Abbott
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000978:Antiparkinson Agents / Q000009:adverse effects* / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D003024:Clozapine / Q000008:administration & dosage* / Q000009:adverse effects; D003987:Dibenzothiazepines / Q000008:administration & dosage* / Q000009:adverse effects; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011569:Psychiatric Status Rating Scales; D011605:Psychoses, Substance-Induced / Q000188:drug therapy*; D000069348:Quetiapine Fumarate; D016896:Treatment Outcome
chemical_list: D000978:Antiparkinson Agents; D014150:Antipsychotic Agents; D003987:Dibenzothiazepines; D000069348:Quetiapine Fumarate; D003024:Clozapine